Daniel Robert Kuritzkes MD
Professor of Medicine, Brigham and Women's Hospital
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-5500
Dr. Kuritzkes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Daniel Kuritzkes is an infectious disease specialist based in Boston, MA. He received a combined BS and MS in Molecular Biophysics and Biochemistry from Yale in 1978, graduated from Harvard Medical School in 1983 and completed his internship and residency in internal medicine at Massachusetts General Hospital (1983-86). He also completed a fellowship in infectious diseases from 1986 to 1990 at Massachusetts General Hospital/Harvard Medical School. Dr. Kuritzkes has authored more than 350 publications, including studies on HIV-related topics in journals such as Cell, The New England Journal of Medicine and The Journal of Infectious Diseases. He has been involved in clinical trials focused on HIV treatment and laboratory studies of HIV drug resistance.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1986 - 1990
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1983 - 1986
Harvard Medical SchoolClass of 1983
Certifications & Licensure
MA State Medical License 1984 - 2027
CO State Medical License 1990 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2016
- CMS Meaningful Use Stage 2 Certification Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2016
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2016
Clinical Trials
- Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
- Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
- A Comparison of Two Tests for Anti-HIV Drug Resistance
Publications & Presentations
PubMed
- Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.Josep M Llibre, Diego Ripamonti, Anna M Geretti, Raquel Martin-Iguacel, Paul E Sax
Clinical Infectious Diseases. 2026-05-20 - Management of patients hospitalized for SARS-CoV-2 infection: A real-world economic evaluation from the hospital perspective.Andre C Kalil, Mohsen Yaghoubi, Neera Ahuja, Ananth Kadambi, Thomas Oppelt
American Journal of Health-System Pharmacy. 2026-04-11 - Understanding the clinical implications of the barrier against resistance in antiretroviral treatment.Josep M Llibre, Daniel R Kuritzkes, Raquel Martin-Iguacel, Diego Ripamonti, Ravindra K Gupta
Clinical Infectious Diseases. 2026-04-07
Journal Articles
- The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Post-Treatment Controllers Identified from 14 Clinical StudiesElizabeth Connick, Michael C Sneller, Jonathan Z Li, Paul Volberding, Daniel R Kuritzkes, Robert T Schooley, David Margolis, Daniel Skiest, John W Mellors, Ronald Mits..., The Journal of Infectious Diseases
- Targeted HIV Testing at Birth Supported by Low and Predictable Mother‐to‐Child Transmission Risk in BotswanaDaniel Kuritzkes, MD, Journal of the International AIDS Society
Authored Content
- Hematopoietic Stem Cell Transplantation for HIV CureJanuary 2016
Press Mentions
8 Children Have Now Died From Flu in Mass. This SeasonMarch 9th, 2026- Florida Flu Cases Rise; Lee Health to Offer GuidanceDecember 3rd, 2025
- Here's When to Get Your COVID and Flu Shots so You're Protected on ThanksgivingOctober 30th, 2025
Grant Support
- Multidisciplinary HIV Training ProgramBRIGHAM AND WOMEN'S HOSPITAL1990–2030
- A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in BotswanaHARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH2023–2028
- A clinical trial to evaluate the impact of broadly neutralizing antibody VRC01 on HIV viral reservoir and maintenance of suppression in a cohort of early-treated children in BotswanaTHE BOTSWANA HARVARD HEALTH PARTNERSHIP2018–2027
- Boston HIV CTUBRIGHAM AND WOMEN'S HOSPITAL2007–2027
- HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapyBRIGHAM AND WOMEN'S HOSPITAL2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
